A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

Exclusive: ASA calls number of parallel probes ‘significant’ and describes tackling issue as ‘priority’ after it issued ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

Ozempic and other semaglutide medications work by mimicking GLP-1—a natural hormone produced in the intestines that regulates ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more cases linking them to ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Outside the game, commercials are a big part of Super Bowl Sunday. Companies pay large amounts of money for their ...